Approval · Notice of Compliance 23965 · 2020
INREBIC: Notice of Compliance 23965
Issued July 27, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23965
- Date
- July 27, 2020
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INREBIC | 02502445 | Marketed |
Medicinal ingredients
- FEDRATINIB HYDROCHLORIDE 100 MG per CAP